AMG479

Ramucirumab · Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AMG479, covering 2017-05-10 to 2017-05-10. Get the full timeline:

Most recent: Clinical Trial Update: Study of RAD001 + AMG479 for Patients With Advanced Solid Tumors [Phase 1]